HORIZON-HLTH-DISEASE-2022-06-two-stage-04: Development of new effective therapies for rare diseases

Year: 2022
Type of action: RIA
Expected EU contribution per project: 8M€
Deadline: first stage 01/02/2022 second stage 06/09/2022